Literature DB >> 16897604

Biological markers to predict previous alcohol withdrawal seizures: a risk assessment.

T Hillemacher1, H Frieling, K Bayerlein, J Wilhelm, J Kornhuber, S Bleich.   

Abstract

Recent studies have shown that both, elevated homocysteine and prolactin plasma levels are associated with a higher risk of alcohol withdrawal seizures. The aim of this study was to evaluate the predictive qualities of a combined assessment of homocysteine and prolactin for previous alcohol withdrawal seizures. Therefore, 117 male patients suffering from alcohol dependency were included into the study. Homocysteine was measured directly at admission, prolactin the morning following admission for detoxification treatment. Pearson's chi(2)-test showed significant results for the combined assessment of both parameters (chi(2) = 14.71, p = 0.001). Multivariate logistic regression also revealed significant predictive qualities (p = 0.001, OR = 9.23, 95%CI = 2.36-36.05). A combination of both, homocysteine and prolactin, may help to assess the individual risk of alcohol withdrawal seizures in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897604     DOI: 10.1007/s00702-006-0541-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  25 in total

1.  Enzyme conversion immunoassay for determining total homocysteine in plasma or serum.

Authors:  F Frantzen; A L Faaren; I Alfheim; A K Nordhei
Journal:  Clin Chem       Date:  1998-02       Impact factor: 8.327

2.  Impact of acute and chronic ethanol exposure on prolactin in both male and female rats.

Authors:  N V Emanuele; N Lapaglia; M A Emanuele
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

3.  Effects of N-methyl-D-aspartate and kainic acid on prolactin secretion in prepubertal female rats.

Authors:  L Pinilla; D González; M Tena-Sempere; R Aguilar; E Aguilar
Journal:  Eur J Endocrinol       Date:  1996-10       Impact factor: 6.664

4.  Alcoholism-associated hyperhomocysteinemia and previous withdrawal seizures.

Authors:  Kristina Bayerlein; Thomas Hillemacher; Udo Reulbach; Brigitte Mugele; Wolfgang Sperling; Johannes Kornhuber; Stefan Bleich
Journal:  Biol Psychiatry       Date:  2005-06-15       Impact factor: 13.382

5.  [Differential diagnostic value of postictal serum prolactin determination].

Authors:  V F Mautner; E Schneider; L Hanisch
Journal:  Nervenarzt       Date:  1987-07       Impact factor: 1.214

Review 6.  EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force.

Authors:  G Bråthen; E Ben-Menachem; E Brodtkorb; R Galvin; J C Garcia-Monco; P Halasz; M Hillbom; M A Leone; A B Young
Journal:  Eur J Neurol       Date:  2005-08       Impact factor: 6.089

7.  Oxidative stress and an altered methionine metabolism in alcoholism.

Authors:  S Bleich; K Spilker; C Kurth; D Degner; M Quintela-Schneider; K Javaheripour; E Rüther; J Kornhuber; J Wiltfang
Journal:  Neurosci Lett       Date:  2000-11-03       Impact factor: 3.046

8.  NMDA receptor antagonists block stress-induced prolactin release in female rats at estrus.

Authors:  C Bregonzio; C E Navarro; A O Donoso
Journal:  Eur J Pharmacol       Date:  1998-06-05       Impact factor: 4.432

9.  Ethanol-related prolactin responses and risk for alcoholism.

Authors:  M A Schuckit; D C Parker; L R Rossman
Journal:  Biol Psychiatry       Date:  1983-10       Impact factor: 13.382

10.  Alcohol modulation of single GABA(A) receptor-channel kinetics.

Authors:  H Tatebayashi; H Motomura; T Narahashi
Journal:  Neuroreport       Date:  1998-06-01       Impact factor: 1.837

View more
  3 in total

1.  Other research interests regarding biomarkers in the population with alcohol dependency.

Authors:  Adegboyega Oyemade
Journal:  Innov Clin Neurosci       Date:  2011-04

2.  Indicators for elevated risk factors for alcohol-withdrawal seizures: an analysis using a random forest algorithm.

Authors:  Thomas Hillemacher; Helge Frieling; Julia Wilhelm; Annemarie Heberlein; Deniz Karagülle; Stefan Bleich; Bernd Lenz; Johannes Kornhuber
Journal:  J Neural Transm (Vienna)       Date:  2012-05-24       Impact factor: 3.575

3.  Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.

Authors:  E Domi; E Barbier; E Augier; G Augier; D Gehlert; R Barchiesi; A Thorsell; L Holm; M Heilig
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.